Nuveen Asset Management, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,128,890
+44.8%
278,441
+20.1%
0.00%
+33.3%
Q2 2023$8,378,005
+86431.8%
231,885
-11.0%
0.00%
-25.0%
Q1 2023$9,682
-9.9%
260,409
+9.8%
0.00%0.0%
Q4 2022$10,751
-99.9%
237,274
+69.0%
0.00%0.0%
Q3 2022$9,805,000
+1.5%
140,397
-2.4%
0.00%0.0%
Q2 2022$9,656,000
-5.7%
143,844
+16.7%
0.00%
+33.3%
Q1 2022$10,236,000
-50.9%
123,208
-13.3%
0.00%
-50.0%
Q4 2021$20,834,000
-25.2%
142,031
-9.8%
0.01%
-33.3%
Q3 2021$27,869,000
+4.1%
157,530
-4.9%
0.01%
+12.5%
Q2 2021$26,761,000
-27.3%
165,672
-22.9%
0.01%
-33.3%
Q1 2021$36,802,000
-20.1%
214,841
+2.5%
0.01%
-25.0%
Q4 2020$46,040,000
+44.2%
209,614
+9.0%
0.02%
+33.3%
Q3 2020$31,925,000
+53.0%
192,263
+5.2%
0.01%
+50.0%
Q2 2020$20,871,000
+53.7%
182,806
+3.5%
0.01%
+14.3%
Q1 2020$13,575,000
-14.5%
176,596
+43.3%
0.01%
+16.7%
Q4 2019$15,875,000
+64.2%
123,195
-0.7%
0.01%
+50.0%
Q3 2019$9,668,000
-14.6%
124,095
+12.9%
0.00%0.0%
Q2 2019$11,317,000109,8730.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders